Blueprint raises $125 million follow-on

Blueprint Medicines Corp. (NASDAQ:BPMC) raised $125 million through the sale of 5 million shares at $25 in a follow-on led by Goldman Sachs, Morgan Stanley, Cowen, JMP Securities and Wedbush PacGrow. The price is a 12% discount to Blueprint’s close of $28.43 on Tuesday, before the offering was announced after market.

The stock added $1.46 on Thursday to $27.66...